RTGN and TAG transparent 2023-12-04_15-50-47.png
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy
22 févr. 2024 06h05 HE | RetinalGeniX Technologies, Inc.
RetinalGeniX Granted A New Patent for an Affordable and Effective Device and Method To Detect Ocular And Systemic Diseases
logo.png
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method
07 févr. 2024 08h00 HE | Enlivex Therapeutics Ltd
Nes-Ziona, Israel, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd., (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that...
DUOT_PR_AI_Patent
Duos Granted AI Patent
07 févr. 2024 08h00 HE | Duos Technologies Group, Inc
Duos Granted AI Patent Rail safety patent with supervised machine learning, proactively detects defects, identifies derailment risks for Rail Safety
Aggreko cooling towers
Aggreko Awarded U.S. Patent for Rental Cooling Tower Systems
06 févr. 2024 09h05 HE | Aggreko
Aggreko was granted a patent by the USPTO for a cooling tower within an ISO-compliant shipping container frame.
Cheer Holding Secures National Invention Patent for Revolutionary AI Core Technology
06 févr. 2024 07h30 HE | Cheer Holding, Inc.
BEIJING, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) ("Cheer Holding," or the "Company"), a leading provider of advanced mobile internet infrastructure and platform...
IFI-GenAI-report-leaders-patent-applications
Digital Science announces new AI patent study results: IBM leads Google and Microsoft as race to next generation AI heats up
06 févr. 2024 05h00 HE | Digital Science
Digital Science announces the findings of a new patent study by IFI CLAIMS on trends in artificial intelligence and Generative AI.
Algernon Logo 1.png
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD
31 janv. 2024 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a Canadian clinical stage...
Logo_Anaqua-Color.png
アナクアとAnyGen AIが戦略的パートナーシップを 締結、知財市場にAIソリューションを提供
30 janv. 2024 07h00 HE | Anaqua
ボストン, Jan. 30, 2024 (GLOBE NEWSWIRE) -- 知的財産管理そして発明管理ソリューションの大手テクノロジープロバイダーであるアナクア社(Anaqua)が、業界標準の大規模言語モデル(LLM)を含む最先端の AI ソリューションを 知財市場に提供するために、AIアプリケーション・インフラストラクチャー会社のAnyGen...
Logo_Anaqua-Color.png
Anaqua et AnyGen AI forment un partenariat stratégique pour fournir des solutions d'IA au marché de la propriété intellectuelle
30 janv. 2024 07h00 HE | Anaqua
BOSTON, 30 janv. 2024 (GLOBE NEWSWIRE) -- Anaqua, le leader mondial de l'innovation et de la gestion de la propriété intellectuelle (PI), a annoncé aujourd'hui un partenariat stratégique avec la...
Logo_Anaqua-Color.png
Anaqua and AnyGen AI Form Strategic Partnership to Deliver AI Solutions to the IP Market
30 janv. 2024 07h00 HE | Anaqua
Anaqua partners with artificial intelligence (AI) application infrastructure company AnyGen AI to deliver AI solutions to the Intellectual Property market